loader icon
endoc logo

Our Location

about1

About Endoc Biotech

Endoc Biotech is an innovation-driven biopharmaceutical company, specializing in the Fermenter-based manufacturing of Active Pharmaceutical Ingredients (APIs). Established in 2020 in Rajkot, Endoc operates a world-class pharmaceutical manufacturing facility that adheres to rigorous regulatory standards, including FDA, WHO, and EU compliance. By following cGMP and regulatory guidelines, Endoc Biotech ensures the production of high-quality drug molecules.

Endoc has quickly emerged as a leading manufacturer of Mupirocin in the pharmaceutical market, gaining recognition for excellence and reliability.

With state-of-the-art manufacturing facilities and a team of seasoned professionals, Endoc Biotech excels in bulk drug and intermediate manufacturing. Our robust infrastructure, including cutting-edge research and development labs, plant equipment, and a dedicated workforce, is located in Rajkot—one of India’s premier industrial hubs. We are committed to providing reliable services to clients worldwide, backed by our expertise and unwavering commitment to quality.

whogmp

23573 SQ.M

Total Area

whogmp

5 MTPA

Production Capacity

whogmp

20

Total Reactors

whogmp

10

Total Fermenter

whogmp

2

Pharma Blocks

whogmp

100 KL

Total Capacity

Global Foot Prints
Technical Expertise

Endoc Biotech is led by a team of experts specializing in Fermenter technology, bulk drug manufacturing, and high-quality API production. With deep industry experience, we ensure every process meets the highest standards of efficiency, quality, and regulatory compliance.

Global Foot Prints
Quality Commitment

At Endoc Biotech, we ensure the highest quality standards by adhering to cGMP guidelines and maintaining a strong quality management system. Every stage, from raw materials to finished products, is rigorously tested to guarantee consistency, safety, and efficacy.

Global Foot Prints
Global Foot Prints

Endoc redefines the global pharmaceutical network by providing its experience & expertise in complex molecules produced at state of the art manufacturing facilities, catering to a global audience. we are committed to meeting global healthcare needs with innovation, reliability, and excellence.

Product

  • Mupirocin (Commercialized)
    Therapeutic category:

    Topical Antibiotic

    CAS Number:

    12650-69-0

    Grade:

    USP/EP/IP

    8047-67-4
  • Mupirocin (Commercialized)
    Therapeutic category:

    Topical Antibiotic

    CAS Number:

    12650-69-0

    Grade:

    USP/EP/IP

    8047-67-4
  • Tacrolimus (Upcoming)
    Therapeutic category:

    Immunosuppresant

    CAS Number:

    104987-11-3

    Grade:

    USP/EP/IP

    IronDeficiency
  • Mupirocin (Commercialized)
    Therapeutic category:

    Topical Antibiotic

    CAS Number:

    12650-69-0

    Grade:

    USP/EP/IP

    8047-67-4
  • Mupirocin (Commercialized)
    Therapeutic category:

    Topical Antibiotic

    CAS Number:

    12650-69-0

    Grade:

    USP/EP/IP

    8047-67-4
  • Tacrolimus (Upcoming)
    Therapeutic category:

    Immunosuppresant

    CAS Number:

    104987-11-3

    Grade:

    USP/EP/IP

    IronDeficiency

ⓒ Copyright 2025 Endoc Biotech . All rights reserved

Develop By Ocean Infotech